Polymer Microarrays for Biomaterial Development
Poster Apr 01, 2015
Simmonte, M.J.1, Dhaliwal, K.2, Cuschieri, K.3, Graham, S.V.4, Bradley, M.1
Polymer biomaterials have truly become integrated into modern day healthcare and medical science. These range from the basic, such as culture equipment and blood bags, to the complex, stimuli-dependent hydrogels, and leukocyte filters. Polymer microarrays have greatly improved the discovery of biologically relevant interactions by interrogating a chosen biological material against a library of polymers, simultaneously. In this work, the polymer microarray approach is applied in two different biological contexts to identify promising candidates for biomaterial development, as well as expanding the repertoire of polymer microarray application. Specifically the identification of polymer substrates for: the scavenge of DNA-based DAMPs in a blood based application; and for the enrichment of cancerous and precancerous cervical cells for improved cytology of PreservCyt®-treated LBC samples, has been investigated.
Using this approach, we have identified a number of poly(acrylate), poly(acrylamide), and poly(urethane) candidates that, while resistant to blood cell attachment, were capable of binding to mtDNA and nDNA. A second investigation has also elucidated substrates with preferential binding for fixed cervical cell lines, including the precancerous W12 model. These findings demonstrate the versatility of this experimental approach by providing some of the first examples of molecule-polymer and preserved cell-polymer interactions, identified via microarray.
Despite the developments in conventional PCR, the complexity of multiplex Real Time PCR is still limited due to the lack of sufficient detection channels. To achieve high-end multiplexing capacity on standard Real Time PCR machines, Anapa Biotech has developed the MeltPlex® technology (see box on right).READ MORE
Genome-wide association studies (GWAS) have identified more than 100 genetic loci associated with type 2 diabetes. The majority of these are located in the intergenic or intragenic regions suggesting that the implicated variants may alter chromatin conformation. This, in turn, is likely to influence the expression of nearby or more remotely located genes to alter beta cell function. At present, however, detailed molecular and functional analyses are still lacking for most of these variants. We recently analysed one of these loci and mapped five causal variants in an islet-specific enhancer cluster within the STARD10 gene locus. Here, we aimed to understand how these causal variants influence b-cell function by alteration of the chromatin structure of enhancer clusterREAD MORE